Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis.

PubWeight™: 1.87‹?› | Rank: Top 3%

🔗 View Article (PMID 16357844)

Published in Mod Pathol on January 01, 2006

Authors

Kurt T Patton1, Liang Cheng, Veronica Papavero, Matthew G Blum, Anjana V Yeldandi, Brian P Adley, Chunyan Luan, Leslie K Diaz, Pei Hui, Ximing J Yang

Author Affiliations

1: Department of Pathology, Northwestern University, Feinberg School of Medicine, Chicago, IL 60611, USA.

Articles citing this

Benign metastasizing leiomyoma of the lung: clinicopathologic, immunohistochemical, and micro-RNA analyses. Diagn Mol Pathol (2008) 1.41

Pulmonary benign metastasizing leiomyoma: a case report and literature review. J Thorac Dis (2014) 1.22

Benign metastasizing leiomyoma of the lung. World J Surg Oncol (2013) 1.10

Pulmonary and retroperitoneal benign metastasizing leiomyoma. Clin Exp Reprod Med (2011) 1.04

Benign metastasizing leiomyoma: a rare type of lung metastases-two case reports and review of the literature. Case Rep Oncol Med (2014) 1.02

Locally relapsed and metastatic uterine leiomyoma: a case report. J Med Case Rep (2008) 0.93

Genomic imbalances in benign metastasizing leiomyoma: characterization by conventional karyotypic, fluorescence in situ hybridization, and whole genome SNP array analysis. Cancer Genet (2012) 0.91

Solitary pulmonary nodule of benign metastasizing leiomyoma associated with primary lung cancer: a case report. J Med Case Rep (2011) 0.87

Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models. Eur Respir Rev (2013) 0.85

Pulmonary benign metastasizing leiomyoma: a case report and review of the literature. World J Surg Oncol (2012) 0.84

Benign pulmonary metastasizing leiomyoma of the uterus: A case report. Oncol Lett (2015) 0.83

Incidental benign metastasizing leiomyoma in a patient with bone sarcoma: a case report. Case Rep Surg (2014) 0.82

Benign metastasizing leiomyomatosis (BML): A rare cause of cavitary and cystic pulmonary nodules. Respir Med Case Rep (2015) 0.81

Single-port laparoscopic debulking surgery of variant benign metastatic leiomyomatosis with simultaneous lymphatic spreading and intraperitoneal seeding. Obstet Gynecol Sci (2015) 0.81

Multiple benign metastasizing leiomyomas in the pelvic lymph nodes and biceps muscle: report of a case. Surg Today (2008) 0.81

Clinical benefit of endocrine therapy for benign metastasizing leiomyoma. Int J Clin Oncol (2010) 0.80

Pulmonary benign metastasizing leiomyoma from the uterine leiomyoma: a case report. Pol J Radiol (2015) 0.79

Benign metastasising leiomyoma: a progressive disease despite chemical and surgical castration. BMJ Case Rep (2012) 0.77

Symplastic leiomyoma of uterus--a clinico-pathological dilemma. BMJ Case Rep (2011) 0.75

Benign metastasizing leiomyoma: A review of current literature in respect to the time and type of previous gynecological surgery. PLoS One (2017) 0.75

Benign metastasizing leiomyomas in the lungs: a case study. Kardiochir Torakochirurgia Pol (2016) 0.75

Articles by these authors

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer. J Clin Endocrinol Metab (2005) 4.39

Non-small cell lung cancer. J Natl Compr Canc Netw (2010) 3.93

Bladder cancer: epidemiology, staging and grading, and diagnosis. Urology (2005) 3.40

Adipocyte-specific gene expression and adipogenic steatosis in the mouse liver due to peroxisome proliferator-activated receptor gamma1 (PPARgamma1) overexpression. J Biol Chem (2002) 3.24

An antioxidant response phenotype shared between hereditary and sporadic type 2 papillary renal cell carcinoma. Cancer Cell (2011) 2.78

AlphaB-crystallin is a novel oncoprotein that predicts poor clinical outcome in breast cancer. J Clin Invest (2006) 2.74

Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest (2013) 2.67

Cystic nephroma and mixed epithelial and stromal tumour of the kidney: opposite ends of the spectrum of the same entity? Eur Urol (2007) 2.33

Perivascular epithelioid cell tumor (PEComa) of the uterine cervix associated with intraabdominal "PEComatosis": A clinicopathological study with comparative genomic hybridization analysis. World J Surg Oncol (2004) 2.33

Heterogeneity of Gleason grade in multifocal adenocarcinoma of the prostate. Cancer (2004) 2.22

Immunoglobulin G4-related disease in genitourinary organs: an emerging fibroinflammatory entity often misdiagnosed preoperatively as cancer. Eur Urol (2012) 2.18

Radial distance of extraprostatic extension measured by ocular micrometer is an independent predictor of prostate-specific antigen recurrence: A new proposal for the substaging of pT3a prostate cancer. Am J Surg Pathol (2007) 2.17

A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk. Cancer Res (2010) 2.15

Immunohistochemical markers in the evaluation of tumors of the urinary bladder: a review. Anal Quant Cytol Histol (2005) 2.14

Feasibility of omitting cortical renorrhaphy during robot-assisted partial nephrectomy: a matched analysis. J Endourol (2015) 2.05

Landscape of somatic single-nucleotide and copy-number mutations in uterine serous carcinoma. Proc Natl Acad Sci U S A (2013) 2.02

Words of wisdom: re: multilocular cystic renal cell carcinoma with focus on clinical and pathobiological aspects. Eur Urol (2013) 2.00

OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol (2004) 1.99

Engagement of collagen-binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells. Cancer Res (2007) 1.90

Multimodal imaging guided photothermal therapy using functionalized graphene nanosheets anchored with magnetic nanoparticles. Adv Mater (2012) 1.86

Small cell carcinoma of the urinary bladder: a clinicopathologic analysis of 64 patients. Cancer (2004) 1.85

FOXO1 inhibits Runx2 transcriptional activity and prostate cancer cell migration and invasion. Cancer Res (2011) 1.80

Small cell carcinoma of the prostate: an immunohistochemical study. Am J Surg Pathol (2006) 1.80

Gene transfer of the Na+,K+-ATPase beta1 subunit using electroporation increases lung liquid clearance. Am J Respir Crit Care Med (2004) 1.79

Prognostic and therapeutic impact of the histopathologic definition of parenchymal epithelial renal tumors. Eur Urol (2010) 1.79

Phase II study of pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer. J Clin Oncol (2009) 1.79

Interobserver reproducibility in the diagnosis of invasive micropapillary carcinoma of the urinary tract among urologic pathologists. Am J Surg Pathol (2010) 1.73

Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int (2009) 1.71

MicroRNA profiling of human kidney cancer subtypes. Int J Oncol (2009) 1.68

Detection of DNA copy number changes and oncogenic signaling abnormalities from gene expression data reveals MYC activation in high-grade papillary renal cell carcinoma. Cancer Res (2007) 1.66

Deficiency of FLCN in mouse kidney led to development of polycystic kidneys and renal neoplasia. PLoS One (2008) 1.64

Clear cell papillary renal cell carcinoma: a distinct histopathologic and molecular genetic entity. Am J Surg Pathol (2008) 1.64

Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas. Clin Cancer Res (2005) 1.63

Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology (2010) 1.61

Multifocal prostate cancer: biologic, prognostic, and therapeutic implications. Hum Pathol (2010) 1.61

A molecular classification of papillary renal cell carcinoma. Cancer Res (2005) 1.60

Expression of RNA-binding protein IMP3 (KOC) in benign urothelium and urothelial tumors. Hum Pathol (2008) 1.60

Evidence for common clonal origin of multifocal lung cancers. J Natl Cancer Inst (2009) 1.59

ERG-TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin. Mod Pathol (2011) 1.59

Multivariate statistical differentiation of renal cell carcinomas based on lipidomic analysis by ambient ionization imaging mass spectrometry. Anal Bioanal Chem (2010) 1.58

HER2/neu as a potential target for immunotherapy in gynecologic carcinosarcomas. Int J Gynecol Pathol (2012) 1.55

The relationship between the extent of surgical margin positivity and prostate specific antigen recurrence in radical prostatectomy specimens. Hum Pathol (2007) 1.53

Phase I/II trial of high intensity focused ultrasound for the treatment of previously untreated localized prostate cancer. J Urol (2007) 1.53

Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin Cancer Res (2004) 1.53

Soft tissue tumors of the urinary bladder, Part I: myofibroblastic proliferations, benign neoplasms, and tumors of uncertain malignant potential. Hum Pathol (2007) 1.52

Prostate cancer diagnosed after initial biopsy with atypical small acinar proliferation suspicious for malignancy is similar to cancer found on initial biopsy. Urology (2002) 1.52

Birt-Hogg-Dubé syndrome: clinicopathologic findings and genetic alterations. Arch Pathol Lab Med (2006) 1.52

Original Gleason system versus 2005 ISUP modified Gleason system: the importance of indicating which system is used in the patient's pathology and clinical reports. Eur Urol (2010) 1.51

Stage pT0 in radical prostatectomy with no residual carcinoma and with a previous positive biopsy conveys a wrong message to clinicians and patients: why is cancer not present in the radical prostatectomy specimen? Eur Urol (2009) 1.51

Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells. Cancer Res (2008) 1.51

Grading of invasive cribriform carcinoma on prostate needle biopsy: an interobserver study among experts in genitourinary pathology. Am J Surg Pathol (2008) 1.49

Cholesterol sulfate imaging in human prostate cancer tissue by desorption electrospray ionization mass spectrometry. Anal Chem (2010) 1.48

Incidence, histology and management of intraluminal thrombus at post-chemotherapy retroperitoneal lymph node dissection. J Urol (2013) 1.48

Robust classification of renal cell carcinoma based on gene expression data and predicted cytogenetic profiles. Cancer Res (2004) 1.47

Plasmacytoid urothelial carcinoma of the bladder. Hum Pathol (2009) 1.46

Role of molecular markers in diagnosis and prognosis of renal cell carcinoma. Anal Quant Cytol Histol (2007) 1.45

Aberrant expression of CARM1, a transcriptional coactivator of androgen receptor, in the development of prostate carcinoma and androgen-independent status. Cancer (2004) 1.45

Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression. Urology (2006) 1.44

Predictors of acute lung injury and severe hypoxemia in patients undergoing operative talc pleurodesis. Ann Thorac Surg (2006) 1.43

2009 update on the classification of renal epithelial tumors in adults. Int J Urol (2009) 1.43

Molecular subclassification of kidney tumors and the discovery of new diagnostic markers. Oncogene (2003) 1.42

Endoloop-assisted laparoscopic partial nephrectomy. J Endourol (2002) 1.42

Evidence supporting the existence of benign teratomas of the postpubertal testis: a clinical, histopathologic, and molecular genetic analysis of 25 cases. Am J Surg Pathol (2013) 1.42

Improved survival in surgical stage I patients with uterine papillary serous carcinoma (UPSC) treated with adjuvant platinum-based chemotherapy. Gynecol Oncol (2005) 1.40

Immunohistochemical expression of endothelin-1 and endothelin-A and endothelin-B receptors in high-grade prostatic intraepithelial neoplasia and prostate cancer. Eur Urol (2007) 1.39

Search for residual prostate cancer on pT0 radical prostatectomy after positive biopsy. Virchows Arch (2007) 1.39

Cyclooxygenase-2 functions as a downstream mediator of lysophosphatidic acid to promote aggressive behavior in ovarian carcinoma cells. Cancer Res (2005) 1.39

Chromosome 17 polysomy: correlation with histological parameters and HER2NEU gene amplification. J Clin Pathol (2013) 1.37

Identification of a transcriptionally active peroxisome proliferator-activated receptor alpha -interacting cofactor complex in rat liver and characterization of PRIC285 as a coactivator. Proc Natl Acad Sci U S A (2002) 1.36

Rare and unusual histological variants of prostatic carcinoma: clinical significance. BJU Int (2008) 1.36

Identification of protein arginine methyltransferase 2 as a coactivator for estrogen receptor alpha. J Biol Chem (2002) 1.36

High-level expression of EphA2 receptor tyrosine kinase in prostatic intraepithelial neoplasia. Am J Pathol (2003) 1.35

Nondestructive, histologically compatible tissue imaging by desorption electrospray ionization mass spectrometry. Chembiochem (2011) 1.34

OCT4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res (2004) 1.34

Ionizing radiation induces prostate cancer neuroendocrine differentiation through interplay of CREB and ATF2: implications for disease progression. Cancer Res (2008) 1.33

The E2F3-Oncomir-1 axis is activated in Wilms' tumor. Cancer Res (2008) 1.33

Drug delivery with upconversion nanoparticles for multi-functional targeted cancer cell imaging and therapy. Biomaterials (2010) 1.33

Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma. Am J Pathol (2002) 1.31

Prostate-specific membrane antigen expression in the neovasculature of gastric and colorectal cancers. Hum Pathol (2009) 1.31

Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum Pathol (2006) 1.31

Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem Mol Morphol (2007) 1.29

alphaB-crystallin is a novel predictor of resistance to neoadjuvant chemotherapy in breast cancer. Breast Cancer Res Treat (2007) 1.29

MicroRNA signatures differentiate uterine cancer tumor subtypes. Gynecol Oncol (2010) 1.29

Histologic grading of noninvasive papillary urothelial neoplasms. Eur Urol (2006) 1.29

Multivariate statistical identification of human bladder carcinomas using ambient ionization imaging mass spectrometry. Chemistry (2011) 1.28

TFE3 break-apart FISH has a higher sensitivity for Xp11.2 translocation-associated renal cell carcinoma compared with TFE3 or cathepsin K immunohistochemical staining alone: expanding the morphologic spectrum. Am J Surg Pathol (2013) 1.28

Adult primary paratesticular mesenchymal tumors with emphasis on a case presentation and discussion of spermatic cord leiomyosarcoma. Diagn Pathol (2014) 1.26

Estrogen receptor beta2 and beta5 are associated with poor prognosis in prostate cancer, and promote cancer cell migration and invasion. Endocr Relat Cancer (2010) 1.26

Lymphoepithelioma-like carcinoma of the prostate. Hum Pathol (2009) 1.26

Microenvironmental regulation of membrane type 1 matrix metalloproteinase activity in ovarian carcinoma cells via collagen-induced EGR1 expression. J Biol Chem (2006) 1.24

Near-infrared light induced in vivo photodynamic therapy of cancer based on upconversion nanoparticles. Biomaterials (2011) 1.24

Expression of EphA2 and Ephrin A-1 in carcinoma of the urinary bladder. Clin Cancer Res (2006) 1.24

Noble metal coated single-walled carbon nanotubes for applications in surface enhanced Raman scattering imaging and photothermal therapy. J Am Chem Soc (2012) 1.23

Human kidney injury molecule-1 (hKIM-1): a useful immunohistochemical marker for diagnosing renal cell carcinoma and ovarian clear cell carcinoma. Am J Surg Pathol (2007) 1.22

Thyroid transcription factor 1 expression in small cell carcinoma of the urinary bladder: an immunohistochemical profile of 44 cases. Hum Pathol (2005) 1.21

Renal cell carcinomas with t(6;11)(p21;q12): A clinicopathologic study emphasizing unusual morphology, novel alpha-TFEB gene fusion point, immunobiomarkers, and ultrastructural features, as well as detection of the gene fusion by fluorescence in situ hybridization. Am J Surg Pathol (2012) 1.21

CD44 expression is a feature of prostatic small cell carcinoma and distinguishes it from its mimickers. Hum Pathol (2008) 1.21